Interpace Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!About IDXG
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.
CEOJack E. Stover
CEOJack E. Stover
Employees89
Employees89
HeadquartersParsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded1986
Founded1986
Employees89
Employees89
IDXG Key Statistics
Market cap38.20M
Market cap38.20M
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume573.44K
Average volume573.44K
High today$1.02
High today$1.02
Low today$0.99
Low today$0.99
Open price$0.99
Open price$0.99
Volume7.03K
Volume7.03K
52 Week high$1.12
52 Week high$1.12
52 Week low$0.381
52 Week low$0.381
Stock Snapshot
With a market cap of 38.2M, Interpace Biosciences(IDXG) trades at $1.00. The stock has a price-to-earnings ratio of 0.00 and currently yields dividends of 0.0%.
As of 2025-11-05, Interpace Biosciences(IDXG) stock has fluctuated between $0.99 and $1.02. The current price stands at $1.00, placing the stock +1.0% above today's low and -2.0% off the high.
The Interpace Biosciences(IDXG)'s current trading volume is 7.03K, compared to an average daily volume of 573.44K.
In the last year, Interpace Biosciences(IDXG) shares hit a 52-week high of $1.12 and a 52-week low of $0.38.
In the last year, Interpace Biosciences(IDXG) shares hit a 52-week high of $1.12 and a 52-week low of $0.38.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IDXG. This list is generated using Robinhood data, and it’s not a recommendation.